Pharma Deals Review, Vol 2005, No 57 (2005)

Font Size:  Small  Medium  Large

Products under Development and the Licensing and Due Diligence Processes

Business Review Editor

Abstract


Nic Scalfarotto of Bristol-Myers Squibb offers a personal perspective. He discusses the reasons for licensing, the associated due diligence and planning, the different stages of the licensing process and where the due diligence process fits into this, and various key roles for due diligence.

Full Text: pdf

Add comment

Creative Commons License
This work is licensed under a Creative Commons Attribution 3.0 License.